240 related articles for article (PubMed ID: 34598085)
1. Development and validation of an ultra-high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of direct oral anticoagulants in human plasma.
Zhang YF; Liu XQ; Wang Y; Xu X; Zhong MK; Zhang P; Ma CL
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122952. PubMed ID: 34598085
[TBL] [Abstract][Full Text] [Related]
2. Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum.
Boehr S; Haen E
Ther Drug Monit; 2017 Feb; 39(1):66-76. PubMed ID: 27861316
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous determination of direct oral anticoagulants in human plasma.
Žideková N; Pršo K; Brisudová K; Babálová L; Bolek T; Sivák Š; Kurča E; Mokrý J; Samoš M; Nosáľ V; Kertys M
J Sep Sci; 2023 Jul; 46(13):e2300084. PubMed ID: 37016565
[TBL] [Abstract][Full Text] [Related]
4. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
Lagoutte-Renosi J; Le Poupon J; Girard A; Montange D; Davani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():43-49. PubMed ID: 30292948
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry.
Zhang M; Moore GA; Chin PKL
Ther Drug Monit; 2020 Jun; 42(3):473-480. PubMed ID: 32053549
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MS.
Brückner L; Beyer-Westendorf J; Tiebel O; Pietsch J
J Thromb Thrombolysis; 2022 May; 53(4):777-787. PubMed ID: 34762222
[TBL] [Abstract][Full Text] [Related]
7. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.
Gouveia F; Bicker J; Santos J; Rocha M; Alves G; Falcão A; Fortuna A
J Pharm Biomed Anal; 2020 Mar; 181():113109. PubMed ID: 31981828
[TBL] [Abstract][Full Text] [Related]
8. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC-MS/MS method.
Zhang WL; Lou D; Zhang DT; Zhang Y; Huang HJ
J Thromb Thrombolysis; 2016 Aug; 42(2):205-11. PubMed ID: 27116356
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).
Noguez JH; Ritchie JC
Methods Mol Biol; 2016; 1383():21-7. PubMed ID: 26660170
[TBL] [Abstract][Full Text] [Related]
10. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.
Wiesen MHJ; Blaich C; Streichert T; Michels G; Müller C
Clin Chem Lab Med; 2017 Aug; 55(9):1349-1359. PubMed ID: 28328524
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
Gous T; Couchman L; Patel JP; Paradzai C; Arya R; Flanagan RJ
Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
[TBL] [Abstract][Full Text] [Related]
12. A rapid and sensitive analytical methodology for the simultaneous biomonitoring of two direct oral anticoagulant drugs and their major metabolites in thromboembolic disordered patients samples for clinical evaluations.
Prakasham K; Pan TY; Tan CH; Wu CF; Chandra P; Cheng CM; Chen W; Tsai WC; Ponnusamy VK; Wu MT
J Chromatogr A; 2024 Feb; 1717():464689. PubMed ID: 38295740
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of direct oral anticoagulants currently used in anticoagulation therapy.
Foerster KI; Huppertz A; Müller OJ; Rizos T; Tilemann L; Haefeli WE; Burhenne J
J Pharm Biomed Anal; 2018 Jan; 148():238-244. PubMed ID: 29055248
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of ten active constituents of Yankening Capsule in rat plasma by ultra high performance liquid chromatography with tandem mass spectrometry.
Wang J; Pang Q; Cen W; Zhu P; Xu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():43-53. PubMed ID: 25531869
[TBL] [Abstract][Full Text] [Related]
15. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
Lindahl S; Dyrkorn R; Spigset O; Hegstad S
Ther Drug Monit; 2018 Jun; 40(3):369-376. PubMed ID: 29578938
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of fourteen compounds of Hedyotis diffusa Willd extract in rats by UHPLC-MS/MS method: Application to pharmacokinetics and tissue distribution study.
Chen X; Zhu P; Liu B; Wei L; Xu Y
J Pharm Biomed Anal; 2018 Sep; 159():490-512. PubMed ID: 30048897
[TBL] [Abstract][Full Text] [Related]
17. A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies.
Zhao Y; Couchman L; Kipper K; Arya R; Patel JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122095. PubMed ID: 32251991
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays.
Kuhn J; Gripp T; Flieder T; Dittrich M; Hendig D; Busse J; Knabbe C; Birschmann I
PLoS One; 2015; 10(12):e0145478. PubMed ID: 26699714
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infections.
LLopis B; Funck-Brentano C; Tissot N; Bleibtreu A; Jaureguiberry S; Fourniols E; Aubry A; Zahr N
J Pharm Biomed Anal; 2020 May; 183():113137. PubMed ID: 32086125
[TBL] [Abstract][Full Text] [Related]
20. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
